INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$46.1M

$46,119,636

Total Sells (Filtered)

$0

$0

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
EIKN P Eikon Therapeutics, Inc. Column Group IV GP, LP • 10% Owner Discretionary BuyΔOwn +91.7% 2026-02-06 $38,119,680MEGAx3 View Form 4 →
EIKN	Eikon Therapeutics, Inc.	Column Group IV GP, LP 10% Owner Discretionary BuyΔOwn +91.7%	2026-02-06	$38,119,680MEGAx3	P	Form 4
EIKN P Eikon Therapeutics, Inc. Foresite Capital Management IV, LLC • 10% Owner Discretionary Buy 2026-02-04 $999,990 View Form 4 →
EIKN	Eikon Therapeutics, Inc.	Foresite Capital Management IV, LLC 10% Owner Discretionary Buy	2026-02-04	$999,990	P	Form 4
EIKN P Eikon Therapeutics, Inc. FRAZIER KENNETH C • Director Discretionary Buy 2026-02-04 $1,999,998Large View Form 4 →
EIKN	Eikon Therapeutics, Inc.	FRAZIER KENNETH C Director Discretionary Buy	2026-02-04	$1,999,998Large	P	Form 4
EIKN P Eikon Therapeutics, Inc. Lux Venture Partners V, LLC • 10% Owner Discretionary Buy 2026-02-04 $2,499,984Large View Form 4 →
EIKN	Eikon Therapeutics, Inc.	Lux Venture Partners V, LLC 10% Owner Discretionary Buy	2026-02-04	$2,499,984Large	P	Form 4
EIKN P Eikon Therapeutics, Inc. Wolfe Josh • Director Discretionary Buy 2026-02-04 $2,499,984Large View Form 4 →
EIKN	Eikon Therapeutics, Inc.	Wolfe Josh Director Discretionary Buy	2026-02-04	$2,499,984Large	P	Form 4